Yesterday an MRI exam on Derek Jeter’s surgically repaired ankle showed mild inflammation after he complained of soreness and today the Yankees shortstop got a cortisone injection.
General manager Brian Cashman stressed that the setback isn’t a severe one, but also told Bryan Hoch of MLB.com that Jeter’s status for Opening Day could be in question:
The season is starting to approach. I know if you asked him, Opening Day would be a certainty. In fairness, I don’t know yet. He’s got to be in position where he could play a full nine innings of defense, be able to do back-to-back [games] and other stuff. There’s some time left. We’ll see how he responds, but I can’t give you certainty.
Players typically take at least a few days off following cortisone injections even if they’re feeling good, at which point Jeter would have about a week to get himself ready for Game 1.
Update (12:58 AM ET): Per Henry Schulman of the San Francisco Chronicle, Samardzija has been diagnosed with a strained pectoral muscle. He’ll be shut down for a week. That’s good news for the Giants, considering the alternatives.
Giants starter Jeff Samardzija will undergo an MRI on his ailing right shoulder, according to NBC Sports Bay Area. The right-hander struggled in a minor league game on Wednesday, surrendering a pair of home runs and hitting a batter. Overall this spring, Samardzija has given up 15 runs (13 earned) on 17 hits (six homers) and seven walks with seven strikeouts in 11 innings.
This may mean Samardzija won’t be ready for the start of the regular season. Derek Holland would likely replace Samardzija in the rotation. Holland had been competing for the No. 5 spot in the Giants’ rotation.
Samardzija led the National League in losses last season with 15, also posting a 4.42 ERA with a 205/32 K/BB ratio in a league-high 207 2/3 innings. Since becoming a starter, Samardzija has been able to avoid injury, making 32 or 33 starts in each of the last five seasons.